Stay updated on IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial page.

Latest updates to the IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe record history now shows a new revision version v3.6.5, replacing the previous v3.6.4.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe revision history now shows a new entry Revision: v3.6.4 and removes Revision: v3.6.3, updating the page's revision history metadata.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page's revision label in the history section updated from v3.6.2 to v3.6.3, representing a minor update to the page's revision tracking.SummaryDifference0.1%

- Check63 days agoChange DetectedThe record’s revision label was updated from v3.6.0 to v3.6.2. This indicates a new revision of the study record.SummaryDifference0.1%

- Check77 days agoChange DetectedA new revision (v3.6.0) on 2026-05-25 added the Contacts/Locations and Study Status sections, and a subsequent 2026-06-12 entry notes that the study is no longer looking for participants. An older revision (v3.5.5) was removed on 2025-07-09.SummaryDifference1%

- Check85 days agoChange DetectedA new revision entry v3.5.5 was added to the revision history, and the earlier revision v3.5.4 was removed, updating the page's versioning metadata.SummaryDifference0.1%

Stay in the know with updates to IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial page.